In ERα-positive breast cancer, DDX5 expression positively correlates with the expression of the poor prognostic marker Her-2, while DDX17 expression correlates with a good prognosis and negatively correlates with the expression of Her-2 (68). This evidence concerns the gene ERBB2 and breast cancer.